Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Respiratory syncytial virus
Recent news which mentions Respiratory syncytial virus
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
April 09, 2024
Tags
Pharmaceuticals
Health care industry
Health & Science
From
CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
Tags
Respiratory syncytial virus
Immunizations
Business News
From
CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
September 22, 2023
Tags
Pfizer Inc
Sanofi SA
Health & Science
From
CNBC.com News
FDA approves Pfizer maternal RSV vaccine for infants
August 21, 2023
Tags
Respiratory syncytial virus
Immunizations
Business News
From
CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
August 02, 2023
Tags
Walgreens Boots Alliance Inc
Business
Biotech and Pharmaceuticals
From
CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
July 26, 2023
Tags
Health care industry
Business News
GSK plc
From
CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
June 29, 2023
Tags
Pfizer Inc
Health & Science
Health care industry
From
CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
June 22, 2023
Tags
Vaccinations
Immunizations
Respiratory syncytial virus
From
CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
June 21, 2023
Tags
Companies
Breaking news
Pfizer Inc
From
CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
June 21, 2023
Tags
Business
Biotech and Pharmaceuticals
Vaccinations
From
CNBC.com News
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
June 21, 2023
Tags
Breaking news
Companies
Science
From
CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
May 31, 2023
Tags
Pfizer Inc
Health & Science
Health care industry
From
CNBC.com News
Here’s what Pfizer and Moderna say is next for their Covid vaccines
May 22, 2023
Tags
Immunizations
Respiratory syncytial virus
US: News
From
CNBC.com News
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
May 18, 2023
Tags
Companies
Science
Breaking News: Business
From
CNBC.com News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
May 16, 2023
Tags
US: News
Biotechnology
Business News
From
CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
May 03, 2023
Tags
Biotech and Pharmaceuticals
Biotechnology
Respiratory syncytial virus
From
CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
February 24, 2023
Tags
Biotech and Pharmaceuticals
Business
Biotechnology
From
CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
January 18, 2023
Tags
Vaccinations
Immunizations
Pfizer Inc
From
CNBC.com News
A nutritionist shares the best snacks to bring on a plane to boost your immune system
December 26, 2022
Tickers
LIFE
Tags
Business travel
Health
COVID/19
From
CNBC.com News
Why flu season is so bad this year
November 10, 2022
Tickers
LIFE
Tags
Business News
Flu
U/S/ Economy
From
CNBC.com News
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows
November 01, 2022
Tags
U/S/ Economy
Respiratory syncytial virus
Business News
From
CNBC.com News
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
May 11, 2022
Tickers
AZN
AZNCF
SNY
Tags
Benzinga
General
News
From
Benzinga
Pfizer's RSV Vaccine Candidate Receives FDA Breakthrough Therapy Tag For Prevention of RSV In Older Adults
March 24, 2022
Tickers
PFE
Tags
Health Care
Market News
PFE
From
Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
December 07, 2021
Tickers
JNJ
Tags
Market News
Biotech
Phase 2 Trial
From
Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
October 04, 2021
Tickers
JNJ
Tags
REspiratory syncytial virus
JNJ
Benzinga
From
Benzinga
Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients
September 02, 2021
Tickers
PFE
Tags
Health Care
Biotech
PFE
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.